banner add

Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patients

The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing system.

from NYT > Health https://ift.tt/2gzu39I
via IFTTT

No comments

Employer Health Costs Are Expected to Spike in 2027

A new U.S. survey anticipates an average increase of 11 percent unless benefits are cut, the highest rate in decades. Other findings also pr...

Theme images by PLAINVIEW. Powered by Blogger.